A detailed history of Cahaba Wealth Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Cahaba Wealth Management, Inc. holds 6,914 shares of PFE stock, worth $189,858. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,914
Previous 8,445 18.13%
Holding current value
$189,858
Previous $236,000 15.25%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$27.7 - $31.39 $42,408 - $48,058
-1,531 Reduced 18.13%
6,914 $200,000
Q2 2024

Aug 05, 2024

SELL
$25.26 - $29.6 $4,925 - $5,772
-195 Reduced 2.26%
8,445 $236,000
Q1 2024

Apr 22, 2024

SELL
$25.89 - $29.73 $30,576 - $35,111
-1,181 Reduced 12.03%
8,640 $239,000
Q4 2023

Jan 23, 2024

SELL
$26.13 - $33.94 $34,909 - $45,343
-1,336 Reduced 11.97%
9,821 $282,000
Q3 2023

Oct 18, 2023

SELL
$32.09 - $37.51 $47,910 - $56,002
-1,493 Reduced 11.8%
11,157 $370,000
Q2 2023

Jul 26, 2023

BUY
$36.12 - $41.79 $13,906 - $16,089
385 Added 3.14%
12,650 $464,000
Q1 2023

May 04, 2023

BUY
$39.39 - $51.28 $2,875 - $3,743
73 Added 0.6%
12,265 $500,000
Q4 2022

Jan 30, 2023

BUY
$41.75 - $54.5 $37,449 - $48,886
897 Added 7.94%
12,192 $624,000
Q3 2022

Oct 18, 2022

BUY
$43.76 - $53.42 $3,282 - $4,006
75 Added 0.67%
11,295 $494,000
Q2 2022

Jul 19, 2022

SELL
$46.53 - $55.17 $79,333 - $94,064
-1,705 Reduced 13.19%
11,220 $588,000
Q1 2022

May 05, 2022

BUY
$45.75 - $56.69 $35,776 - $44,331
782 Added 6.44%
12,925 $634,000
Q4 2021

Feb 01, 2022

BUY
$41.32 - $61.25 $45,699 - $67,742
1,106 Added 10.02%
12,143 $717,000
Q3 2021

Oct 15, 2021

BUY
$39.25 - $50.42 $433,202 - $556,485
11,037 New
11,037 $474,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cahaba Wealth Management, Inc. Portfolio

Follow Cahaba Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cahaba Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cahaba Wealth Management, Inc. with notifications on news.